Crossmark

1-MT inhibits the invasion of CBP-resistant ovarian cancer cells via down-regulating IDO expression and re-activating immune cells function

Published Online: 2020-09-11

Published Print: 2020-12

Authors

Ma, Huihan

Qin, Qian

Mi, Jiaqing

Feng, Qinmei http://orcid.org/0000-0003-4890-8731
Funding

Funding for this research was provided by:

Natural Science Foundation of the Shanxi Science and Technology Department (201701D121156)
License Information

Text and Data Mining valid from 2020-09-11

Version of Record valid from 2020-09-11
More Information

Article History

Received: 23 March 2020

Accepted: 30 July 2020

First Online: 11 September 2020

Ethics approval and consent to participate

: This study was approved by the Human Research Ethical Committee of the Shanxi provincial people’s hospital. Written informed consent was obtained from all individual participants included in the study.

: This manuscript has been approved by all authors for submission. The results from this study were neither published previously, nor are they under consideration for publication elsewhere.

: The authors declare that they have no competing interests. The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Document is current